JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

BeOne Medicines Ltd ADR

Closed

SectorHealthcare

289.09 0.3

Overview

Share price change

24h

Current

Min

284.46

Max

289.09

Key metrics

By Trading Economics

Income

153M

1.3M

Sales

-11M

1.1B

Profit margin

0.114

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+22.54% upside

Dividends

By Dow Jones

Next Earnings

10 lis 2025

Market Stats

By TradingEconomics

Market Cap

22B

Previous open

288.79

Previous close

289.09

News Sentiment

By Acuity

50%

50%

162 / 374 Ranking in Healthcare

BeOne Medicines Ltd ADR Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 maj 2025, 02:16 UTC

Major Market Movers

Asia Pharma Stocks Fall After Trump's Plan to Cut Drug Costs

29 sty 2025, 15:59 UTC

Major Market Movers

ImmunityBio Shares Rise After Collaboration, Supply Agreement With BeiGene

27 lis 2024, 15:22 UTC

Major Market Movers

BeiGene Shares Up on EU Approval for Gastric, Esophageal Cancer Treatment

21 lis 2024, 14:45 UTC

Major Market Movers

Zymeworks Shares Rise 8.3% After Licensed Cancer Treatment Gets FDA OK

22 paź 2024, 18:39 UTC

Major Market Movers

Indaptus Therapeutics Shares Rise After Pact to Develop Cancer Treatment

6 sie 2025, 10:01 UTC

Earnings

BeOne Medicines Narrows FY25 View To Rev $5.0B-$5.3B >ONC

6 sie 2025, 10:01 UTC

Earnings

BeOne Medicines 2Q Rev $1.3B >ONC

6 sie 2025, 10:01 UTC

Earnings

BeOne Medicines 2Q Adj EPS $2.25 >ONC

6 sie 2025, 10:00 UTC

Earnings

BeOne Medicines 2Q EPS 84c >ONC

9 lip 2025, 09:17 UTC

Hot Stocks

Stocks to Watch Wednesday: Freeport-McMoRan, Glencore, Novo Nordisk -- WSJ

7 maj 2025, 10:07 UTC

Earnings

BeiGene Maintains 2025 Expense Guidance of $4.1B to $4.4B >ONC

7 maj 2025, 10:06 UTC

Earnings

BeiGene Backs 2025 Rev $4.9B-$5.3B >ONC

7 maj 2025, 10:05 UTC

Earnings

BeiGene 1Q Net $1.27M >ONC

7 maj 2025, 10:04 UTC

Earnings

BeiGene Says to Rename Company to BeOne Medicines >ONC

7 maj 2025, 10:02 UTC

Earnings

BeiGene 1Q EPS $0.00 >ONC

7 maj 2025, 10:02 UTC

Earnings

BeiGene 1Q Rev Increased 49% >ONC

7 maj 2025, 10:00 UTC

Earnings

BeiGene 1Q Rev $1.12B >ONC

27 lut 2025, 11:07 UTC

Earnings

BeiGene Sees 2025 Rev $4.9B-$5.3B >ONC

27 lut 2025, 11:06 UTC

Earnings

BeiGene 4Q Global BRUKINSA Rev of $828M >ONC

27 lut 2025, 11:06 UTC

Earnings

BeiGene 4Q Loss/Shr 11c >ONC

27 lut 2025, 11:06 UTC

Earnings

BeiGene 4Q Rev $1.13B >ONC

12 lis 2024, 11:01 UTC

Earnings

BeiGene 3Q Loss/Shr 9c >BGNE

12 lis 2024, 11:01 UTC

Earnings

BeiGene 3Q Rev $1B >BGNE

Peer Comparison

Price change

BeOne Medicines Ltd ADR Forecast

Price Target

By TipRanks

22.54% upside

12 Months Forecast

Average 353.15 USD  22.54%

High 373 USD

Low 320 USD

Based on 11 Wall Street analysts offering 12 month price targets forBeOne Medicines Ltd ADR - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

11 ratings

9

Buy

2

Hold

0

Sell

Sentiment

By Acuity

162 / 374 Ranking in Healthcare

News Sentiment

Neutral

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Operating profit

$

About BeOne Medicines Ltd ADR

BeiGene Ltd